FindTrial
Sign In

Identification of facial mimicking in patients with disorder bipolar treated with quetiapine and healthy subjects - Facial mimicking

Identification of facial mimicking in patients with disorder bipolar treated with quetiapine and healthy subjects - Facial mimicking

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-001442-41-IT
Enrollment
Unknown
Registered
2007-04-10
Start date
2006-06-07
Completion date
Unknown
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disorder bipolar MedDRA version: 9.1 Level: SOC Classification code 10037175 Term: Psychiatric disorders

Interventions

Trade Name: SEROQUEL 60CPR RIV 300MG Pharmaceutical Form: Tablet Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 300- Trade Name: CARBOLITHIUM 50CPS 300MG Pharmace

Sponsors

AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: age between 18 and 65 years; bipolar disorder with psicosis free drugs psycotropics from one week 1 month for drugs depot Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Other psicosis;pregnancy and breast-feeding; other medical diseases; skull trauma;abuse or dependence for substance;ipersensivity for drugs; exclusion criteria for lithium

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate the facial mimicking in patients with bipolar disorder treated with quetiapine;Secondary Objective: To evaluate the facial mimicking in patients with bipolar disorder treated with quetiapine;Primary end point(s): Identification of facial mimicking—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026